160 related articles for article (PubMed ID: 16618119)
1. The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy.
Alves ID; Delaroche D; Mouillac B; Salamon Z; Tollin G; Hruby VJ; Lavielle S; Sagan S
Biochemistry; 2006 Apr; 45(16):5309-18. PubMed ID: 16618119
[TBL] [Abstract][Full Text] [Related]
2. The two NK-1 binding sites are distinguished by one radiolabelled substance P analogue.
Kim HR; Lavielle S; Sagan S
Biochem Biophys Res Commun; 2003 Jul; 306(3):725-9. PubMed ID: 12810079
[TBL] [Abstract][Full Text] [Related]
3. Calpha methylation in molecular recognition. Application to substance P and the two neurokinin-1 receptor binding sites.
Sagan S; Lequin O; Frank F; Convert O; Ayoub M; Lavielle S; Chassaing G
Eur J Biochem; 2001 May; 268(10):2997-3005. PubMed ID: 11358518
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P.
Claudel S; Tasseau O; Sagan S; Grison C; Coutrot P; Lavielle S
J Pept Res; 2004 Nov; 64(5):186-93. PubMed ID: 15485556
[TBL] [Abstract][Full Text] [Related]
5. Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor.
Seelig A; Alt T; Lotz S; Hölzemann G
Biochemistry; 1996 Apr; 35(14):4365-74. PubMed ID: 8605185
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the bioactive conformation of the C-terminal tripeptide Gly-Leu-Met-NH2 of substance P using [3-prolinoleucine10]SP analogues.
Quancard J; Karoyan P; Sagan S; Convert O; Lavielle S; Chassaing G; Lequin O
Eur J Biochem; 2003 Jul; 270(13):2869-78. PubMed ID: 12823557
[TBL] [Abstract][Full Text] [Related]
8. Internalization of [3H]substance P analogues in NK-1 receptor transfected CHO cells.
Sagan S; Lavielle S
Biochem Biophys Res Commun; 2001 Apr; 282(4):958-64. PubMed ID: 11352645
[TBL] [Abstract][Full Text] [Related]
9. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
10. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling studies.
Lequin O; Bolbach G; Frank F; Convert O; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Biol Chem; 2002 Jun; 277(25):22386-94. PubMed ID: 11950831
[TBL] [Abstract][Full Text] [Related]
12. High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
Sagan S; Beaujouan JC; Torrens Y; Saffroy M; Chassaing G; Glowinski J; Lavielle S
Mol Pharmacol; 1997 Jul; 52(1):120-7. PubMed ID: 9224821
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
14. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
Bremer AA; Leeman SE; Boyd ND
J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
[TBL] [Abstract][Full Text] [Related]
15. Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway.
Sachon E; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Pept Res; 2002 May; 59(5):232-40. PubMed ID: 11966980
[TBL] [Abstract][Full Text] [Related]
16. Further delineation of the two binding sites (R*(n)) associated with tachykinin neurokinin-1 receptors using [3-Prolinomethionine(11)]SP analogues.
Sagan S; Karoyan P; Chassaing G; Lavielle S
J Biol Chem; 1999 Aug; 274(34):23770-6. PubMed ID: 10446137
[TBL] [Abstract][Full Text] [Related]
17. Selectivity, cooperativity, and reciprocity in the interactions between the delta-opioid receptor, its ligands, and G-proteins.
Alves ID; Ciano KA; Boguslavski V; Varga E; Salamon Z; Yamamura HI; Hruby VJ; Tollin G
J Biol Chem; 2004 Oct; 279(43):44673-82. PubMed ID: 15317820
[TBL] [Abstract][Full Text] [Related]
18. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor.
Girault S; Sagan S; Bolbach G; Lavielle S; Chassaing G
Eur J Biochem; 1996 Aug; 240(1):215-22. PubMed ID: 8797856
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of side-chain conformationally restricted phenylalanines and their use for structure-activity studies on tachykinin NK-1 receptor.
Josien H; Lavielle S; Brunissen A; Saffroy M; Torrens Y; Beaujouan JC; Glowinski J; Chassaing G
J Med Chem; 1994 May; 37(11):1586-601. PubMed ID: 7515443
[TBL] [Abstract][Full Text] [Related]
20. Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes.
Igwe OJ; Kim DC; Seybold VS; Larson AA
J Neurosci; 1990 Nov; 10(11):3653-63. PubMed ID: 1700082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
